Exact Mass: 492.2195
Exact Mass Matches: 492.2195
Found 500 metabolites which its exact mass value is equals to given mass value 492.2195
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
rac-5,6-Epoxy-retinoyl-beta-D-glucuronide
This compound belongs to the family of Diterpene Glycosides. These are diterpenes in which an isoprene unit is glycosylated.
4-Hydroxyretinoic acid glucuronide
4-Hydroxyretinoic acid glucuronide belongs to the class of organic compounds known as diterpene glycosides. These are diterpenoids in which an isoprene unit is glycosylated.
4-[2-[2-[3-Acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxypropanoylamino]propanoylamino]-5-amino-5-oxopentanoic acid
3-[2-[[2-[[2-Acetamido-3-(4-hydroxyphenyl)propanoyl]amino]-3-methylbutanoyl]amino]propanoylamino]-4-oxobutanoic acid
D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D015853 - Cysteine Proteinase Inhibitors Ac-YVAD-CHO (L-709049) is a potent, reversible, specific tetrapeptide interleukin-lβ converting enzyme (ICE) inhibitor with mouse and human Ki values of 3.0 and 0.76 nM. Ac-YVAD-CHO is also a caspase-1 inhibitor. Ac-YVAD-CHO can suppress the production of mature IL-lβ[1][2][3].
2-[4-[2-[(2,4-Difluorophenyl)carbamoyl-heptylamino]ethyl]phenyl]sulfanyl-2-methylpropanoic acid
Ile-Glu-Thr-Asp-fluoromethyl ketone
Loperamide oxide
A - Alimentary tract and metabolism > A07 - Antidiarrheals, intestinal antiinflammatory/antiinfective agents > A07D - Antipropulsives > A07DA - Antipropulsives C78276 - Agent Affecting Digestive System or Metabolism > C266 - Antidiarrheal Agent D005765 - Gastrointestinal Agents > D000930 - Antidiarrheals
L-Alaninamide, N-acetyl-L-tyrosyl-L-valyl-N-((1S)-2-carboxy-1-formylethyl)-
leukotriene-D4
Leukotriene-d4 is practically insoluble (in water) and a weakly acidic compound (based on its pKa). Leukotriene-d4 can be found in a number of food items such as prunus (cherry, plum), horned melon, wasabi, and grass pea, which makes leukotriene-d4 a potential biomarker for the consumption of these food products.
Tepotinib
Mortonol A
Taxuspine W
Taxuspine W is a natural product found in Taxus wallichiana, Taxus baccata, and other organisms with data available.
(3E,7E)-2alpha,10beta,13alpha-triacetoxy-5alpha,20-dihydroxy-3,8-secotaxa-3,7,11-trien-9-one|(3E,7E)-2??,10??,13??-Triacetoxy-5??,20-dihydroxy-3,8-seco-taxa-3,7,11-trien-9-one
1alpha,3beta-dihydroxy-7beta,11beta,15beta-triacetoxy-ent-kaur-16-en-6-one|nervonin C
1alpha,3beta-dihydroxy-6alpha,7beta,11beta-triacetoxy-ent-kaur-16-en-15-one|nervonin B
durumolide H|rel-(1R,3S,4S,13R,14R,7E,11E)-3,13,18-triacetoxy-4-hydroxycembra-7,11,15(17)-trien-16,14-olide
3beta-hydroxy-8beta-<5-hydroxy-4-(2-hydroxy-3-methylvaleroyloxy)tigloyloxy>costunolide|3beta-hydroxy-8beta-[5-hydroxy-4-(2-hydroxy-3-methylvaleroyloxy)tigloyloxy]costunolide
Acetic acid 2,3-bis(3,4,5-trimethoxybenzyl)-4-hydroxybutyl ester
2alpha,7beta,13alpha-triacetoxy-5alpha,9alpha-dihydroxy-2(3->20)abeotaxa-4(20),11-dien-10-one|2??,7??,13??-Triacetoxy-5??,9??-dihydroxy-2(3鈥樏傗垎20)abeotaxa-4(20),11-dien-10-one
2alpha,7beta,10beta-triacetoxy-5alpha,13alpha-dihydroxy-2(3->20)abeotaxa-4(20),11-dien-9-one
2alpha,9alpha,10beta-triacetoxy-11,12-epoxy-20-hydroxytaxa-4-en-13-one
(1alpha,11beta,15beta)-1,6,11-triacetyloxy-15-hydroxy-6,7-seco-ent-kaur-16-en-7,20-olide|isorubesin A
(1S,4S,5S,6R,7R,8S,9S,10S)-1,15-diacetoxy-9-benzoyloxy-4,6,8-trihydroxy-dihydro-beta-agarofuran
6-O-beta-D-glucopyranosyl-beta-D-glucopyranosyl (2E)-3,7-dimethylocta-2,6-dienoate|jasminoside P
8-Ethyl-3-(3-formamidosalicylamido)-2,6-dimethyl-4,9-dioxo-1,5-dioxonan-7-yl isovalerate
GW 9578
Enalapril maleate
D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D000806 - Angiotensin-Converting Enzyme Inhibitors C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C247 - ACE Inhibitor D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
2-ethyl-4-[(Z)-2-[(3-formamido-2-hydroxybenzoyl)amino]but-2-enoyl]oxy-3-(2-methylbutanoyloxy)pentanoic acid
C22H36O12_beta-D-Glucopyranose, 6-O-beta-D-glucopyranosyl-1-O-[(2,6,6-trimethyl-1-cyclohexen-1-yl)carbonyl]
[3,4,5-trihydroxy-6-[[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl] 2,6,6-trimethylcyclohexene-1-carboxylate
[3,4,5-trihydroxy-6-[[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl] 2,6,6-trimethylcyclohexene-1-carboxylate_major
Ala Glu His His
Ala Phe Gln Gln
Ala His Glu His
Ala His His Glu
Ala Gln Phe Gln
Ala Gln Gln Phe
Cys Asp Lys Lys
Cys Gly Lys Trp
Cys Gly Trp Lys
Cys Lys Asp Lys
Cys Lys Gly Trp
Cys Lys Lys Asp
Cys Lys Trp Gly
Cys Asn Arg Thr
Cys Asn Thr Arg
Cys Gln Arg Ser
Cys Gln Ser Arg
Cys Arg Asn Thr
Cys Arg Gln Ser
Cys Arg Ser Gln
Cys Arg Thr Asn
Cys Ser Gln Arg
Cys Ser Arg Gln
Cys Thr Asn Arg
Cys Thr Arg Asn
Cys Trp Gly Lys
Cys Trp Lys Gly
Asp Cys Lys Lys
Asp Lys Cys Lys
Asp Lys Lys Cys
Asp Pro Val Tyr
Asp Pro Tyr Val
Asp Val Pro Tyr
Asp Val Tyr Pro
Asp Tyr Pro Val
Asp Tyr Val Pro
Glu Ala His His
Glu Phe Pro Thr
Glu Phe Thr Pro
Glu His Ala His
Glu His His Ala
Glu Ile Met Thr
Glu Ile Thr Met
Glu Leu Met Thr
Glu Leu Thr Met
Glu Met Ile Thr
Glu Met Leu Thr
Glu Met Thr Ile
Glu Met Thr Leu
Glu Pro Phe Thr
Glu Pro Thr Phe
Glu Thr Phe Pro
Glu Thr Ile Met
Glu Thr Leu Met
Glu Thr Met Ile
Glu Thr Met Leu
Glu Thr Pro Phe
Phe Ala Gln Gln
Phe Glu Pro Thr
Phe Glu Thr Pro
Phe Asn Asn Val
Phe Asn Val Asn
Phe Pro Glu Thr
Phe Pro Thr Glu
Phe Gln Ala Gln
Phe Gln Gln Ala
Phe Thr Glu Pro
Phe Thr Pro Glu
Phe Val Asn Asn
Gly Cys Lys Trp
Gly Cys Trp Lys
Gly Lys Cys Trp
Gly Lys Trp Cys
Gly Trp Cys Lys
Gly Trp Lys Cys
His Ala Glu His
His Ala His Glu
His Glu Ala His
His Glu His Ala
His His Ala Glu
His His Glu Ala
Ile Glu Met Thr
Ile Glu Thr Met
Ile Met Glu Thr
Ile Met Thr Glu
Ile Thr Glu Met
Ile Thr Met Glu
Lys Cys Asp Lys
Lys Cys Gly Trp
Lys Cys Lys Asp
Lys Cys Trp Gly
Lys Asp Cys Lys
Lys Asp Lys Cys
Lys Gly Cys Trp
Lys Gly Trp Cys
Lys Lys Cys Asp
Lys Lys Asp Cys
Lys Met Asn Thr
Lys Trp Cys Gly
Lys Trp Gly Cys
Leu Glu Met Thr
Leu Glu Thr Met
Leu Met Glu Thr
Leu Met Thr Glu
Leu Thr Glu Met
Leu Thr Met Glu
Met Glu Ile Thr
Met Glu Leu Thr
Met Glu Thr Ile
Met Glu Thr Leu
Met Ile Glu Thr
Met Ile Thr Glu
Met Leu Glu Thr
Met Leu Thr Glu
Met Thr Glu Ile
Met Thr Glu Leu
Met Thr Ile Glu
Met Thr Leu Glu
Asn Cys Arg Thr
Asn Cys Thr Arg
Asn Phe Asn Val
Asn Phe Val Asn
Asn Asn Phe Val
Asn Asn Val Phe
Asn Arg Cys Thr
Asn Arg Thr Cys
Asn Thr Cys Arg
Asn Thr Arg Cys
Asn Val Phe Asn
Asn Val Asn Phe
Pro Asp Val Tyr
Pro Asp Tyr Val
Pro Glu Phe Thr
Pro Glu Thr Phe
Pro Phe Glu Thr
Pro Phe Thr Glu
Pro Thr Glu Phe
Pro Thr Phe Glu
Pro Val Asp Tyr
Pro Val Tyr Asp
Pro Tyr Asp Val
Pro Tyr Val Asp
Gln Ala Phe Gln
Gln Ala Gln Phe
Gln Cys Arg Ser
Gln Cys Ser Arg
Gln Phe Ala Gln
Gln Phe Gln Ala
Gln Gln Ala Phe
Gln Gln Phe Ala
Gln Arg Cys Ser
Gln Arg Ser Cys
Gln Ser Cys Arg
Gln Ser Lys Met
Gln Ser Arg Cys
Arg Cys Asn Thr
Arg Cys Gln Ser
Arg Cys Ser Gln
Arg Cys Thr Asn
Arg Asn Cys Thr
Arg Asn Thr Cys
Arg Gln Cys Ser
Arg Gln Ser Cys
Arg Ser Cys Gln
Arg Ser Gln Cys
Arg Thr Cys Asn
Arg Thr Asn Cys
Ser Cys Gln Arg
Ser Cys Arg Gln
Ser Gln Cys Arg
Ser Gln Arg Cys
Ser Arg Cys Gln
Ser Arg Gln Cys
Thr Cys Asn Arg
Thr Cys Arg Asn
Thr Glu Phe Pro
Thr Glu Ile Met
Thr Glu Leu Met
Thr Glu Met Ile
Thr Glu Met Leu
Thr Glu Pro Phe
Thr Phe Glu Pro
Thr Phe Pro Glu
Thr Ile Glu Met
Thr Ile Met Glu
Thr Leu Glu Met
Thr Leu Met Glu
Thr Met Glu Ile
Thr Met Glu Leu
Thr Met Ile Glu
Thr Met Leu Glu
Thr Asn Cys Arg
Thr Asn Met Lys
Thr Asn Arg Cys
Thr Pro Glu Phe
Thr Pro Phe Glu
Thr Arg Cys Asn
Thr Arg Asn Cys
Val Asp Pro Tyr
Val Asp Tyr Pro
Val Phe Asn Asn
Val Asn Phe Asn
Val Asn Asn Phe
Val Pro Asp Tyr
Val Pro Tyr Asp
Val Tyr Asp Pro
Val Tyr Pro Asp
Trp Cys Gly Lys
Trp Cys Lys Gly
Trp Gly Cys Lys
Trp Gly Lys Cys
Trp Lys Cys Gly
Trp Lys Gly Cys
Tyr Asp Pro Val
Tyr Asp Val Pro
Tyr Pro Asp Val
Tyr Pro Val Asp
Tyr Val Asp Pro
Tyr Val Pro Asp
N-Ac-Tyr-Val-Ala-Asp-CHO
Ac-YVAD-CHO (L-709049) is a potent, reversible, specific tetrapeptide interleukin-lβ converting enzyme (ICE) inhibitor with mouse and human Ki values of 3.0 and 0.76 nM. Ac-YVAD-CHO is also a caspase-1 inhibitor. Ac-YVAD-CHO can suppress the production of mature IL-lβ[1][2][3].
6-O-?-D-Glucopyranosyl-1-O-[(2,6,6-trimethyl-1-cyclohexen-1-yl)carbonyl]-?-D-glucopyranose
[6-(2,6-dimethylnaphthalene-1-carbonyl)naphthalen-2-yl]-(2,6-dimethylnaphthalen-1-yl)methanone
tepotinib
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C164000 - c-Met-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor D000970 - Antineoplastic Agents
(S)-1-((S)-2-(((R)-1-ethoxy-1-oxo-4-phenylbutan-2-yl)amino)propanoyl)pyrrolidine-2-carboxylic acid compound with maleic acid (1:1)
2,2-[1,4-Phenylenebis(methyleneimino-4,1-phenyleneoxy)]bis[2-methylpropanoic acid]
[3-chloro-4-(4-pentylbenzoyl)oxyphenyl] 4-pentylbenzoate
5,6-Epoxyretinoyl glucuronide
D020011 - Protective Agents > D000975 - Antioxidants > D002338 - Carotenoids
4-Oxo-2-phenylmethanesulfonyl-octahydro-pyrrolo[1,2-A]pyrazine-6-carboxylic acid [1-(N-hydroxycarbamimidoyl)-piperidin-4-ylmethyl]-amide
loperamide
A - Alimentary tract and metabolism > A07 - Antidiarrheals, intestinal antiinflammatory/antiinfective agents > A07D - Antipropulsives > A07DA - Antipropulsives C78276 - Agent Affecting Digestive System or Metabolism > C266 - Antidiarrheal Agent D005765 - Gastrointestinal Agents > D000930 - Antidiarrheals
3-[[1-[[2-[[2-Acetamido-3-(4-hydroxyphenyl)propanoyl]amino]-3-methylbutanoyl]amino]-1-oxopropan-2-yl]amino]-4-oxobutanoic acid
3-[1-azepanyl-[1-[(4-fluorophenyl)methyl]-5-tetrazolyl]methyl]-6,7-dimethoxy-1H-quinolin-2-one
(1R,2S,4aS,5R,6S,8R,8aS)-8a-[(acetyloxy)methyl]-5,6-dimethyl-5-[(2R,3aR,6aR)-2,3,3a,6a-tetrahydrofuro[2,3-b]furan-2-yl]octahydro-2H-spiro[naphthalene-1,2-oxirane]-2,8-diyl diacetate
3-[[4-[[4-(2-methoxyphenyl)-1-piperazinyl]-oxomethyl]cyclohexyl]methyl]-2-sulfanylidene-1H-quinazolin-4-one
8-[[4-(5-Chloro-2-methylphenyl)-1-piperazinyl]methyl]-3-methyl-7-(2-phenylethyl)purine-2,6-dione
N-[(E)-[3-[[4-(4-fluorophenyl)piperazin-1-yl]methyl]-4-methoxyphenyl]methylideneamino]-4-hydroxy-3-methoxybenzamide
(1S,9R,10R,11R)-10-(hydroxymethyl)-6-oxo-N-(4-phenylphenyl)-12-(pyridin-4-ylmethyl)-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
2-[(3R,6aR,8S,10aR)-3-hydroxy-1-[[3-(trifluoromethyl)phenyl]methyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-(phenylmethyl)acetamide
(1R,9S,10S,11S)-10-(hydroxymethyl)-6-oxo-N-(4-phenylphenyl)-12-(pyridin-4-ylmethyl)-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
4-(beta-D-glucopyranuronosyloxy)retinoic acid
A hydroxyretinoic glucuronide that is all-trans-4-hydroxyretinoic acid attached to a beta-D-glucuronic acid residue via a glycosidic linkage.
1-O-all-trans-4-hydroxyretinoyl-beta-glucuronic acid
A hydroxyretinoic glucuronide obtained by the glycosylation of the carboxy group of all-trans-4-hydroxyretinoic acid with beta-glucuronic acid.
methyl 6-{[4-deoxy-4-formamido-alpha-D-rhamnopyranosyl-(1->3)-4-deoxy-4-formamido-alpha-D-rhamnopyranosyl]oxy}hexanoate
2-Ethyl-4-[(z)-2-[(3-formamido-2-hydroxybenzoyl)amino]but-2-enoyl]oxy-3-(2-methylbutanoyloxy)pentanoic acid
1-O-(5,6-epoxyretinoyl)-beta-D-glucuronic acid
A retinoid that is 5,6-epoxyretinoic acid in which the carboxy proton has been replaced by a beta-D-glucuronyl residue.
3,12-bis(acetyloxy)-10,14-dihydroxy-7,11,16,16-tetramethyl-9-oxotricyclo[9.3.1.1⁴,⁸]hexadeca-1,7-dien-6-yl acetate
(1r,2s)-1-[(1r,4as,8s,9r,11ar)-1-(acetyloxy)-8,9-dihydroxy-7-methyl-11-methylidene-1h,4ah,5h,8h,9h,10h,11ah-cyclonona[c]pyran-4-yl]-1-(acetyloxy)-4-methylpent-3-en-2-yl acetate
4,8,11b-trimethyl-4-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-1h,2h,3h,4ah,5h,6h,10ah,11h-phenanthro[3,2-b]furan-7,9-dione
(1s,2r,3s,4r,7s,8z,12r,13s,14s)-12,14-bis(acetyloxy)-3-hydroxy-4,9,13,17-tetramethyl-5-oxo-6-oxatricyclo[11.4.0.0³,⁷]heptadeca-8,16-dien-2-yl acetate
(1r,2s,4ar,5r,6s,7r,8r,8ar)-2,7-bis(acetyloxy)-5-[2-(furan-3-yl)ethyl]-8-hydroxy-5,6-dimethyl-hexahydro-2h-spiro[naphthalene-1,2'-oxiran]-8a-ylmethyl acetate
(2r,3s)-4-hydroxy-2,3-bis[(3,4,5-trimethoxyphenyl)methyl]butyl acetate
(1s,2r,3s,4r,7s,8z,12r,13s,14s)-12,14-bis(acetyloxy)-3-hydroxy-4,9,13-trimethyl-17-methylidene-5-oxo-6-oxatricyclo[11.4.0.0³,⁷]heptadec-8-en-2-yl acetate
(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl 2,6,6-trimethylcyclohex-1-ene-1-carboxylate
2,11-bis(acetyloxy)-6,8-dihydroxy-5,5,9-trimethyl-14-methylidene-3-oxotetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-15-yl acetate
(1e,3s,4r,6s,9r,11s,12s,14s)-3,12-bis(acetyloxy)-9,14-dihydroxy-7,11,16,16-tetramethyl-10-oxotricyclo[9.3.1.1⁴,⁸]hexadeca-1,7-dien-6-yl acetate
(4r,4as,10ar,11br)-4,8,11b-trimethyl-4-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-1h,2h,3h,4ah,5h,6h,10ah,11h-phenanthro[3,2-b]furan-7,9-dione
5-(3-chloro-5-formyl-2,6-dihydroxy-4-methylphenyl)-3-methyl-1-(1,2,6-trimethyl-3-oxocyclohexyl)pent-3-en-2-yl butanoate
(1r,2r,3r,4s,6r,7s,9s,10s,11s,13s)-6,7-bis(acetyloxy)-3,11-dihydroxy-5,5,9-trimethyl-14-methylidene-15-oxotetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-2-yl acetate
(1r,2r,3r,4s,6r,7s,9s,10s,11s,13s)-2,6-bis(acetyloxy)-3,7-dihydroxy-5,5,9-trimethyl-14-methylidene-15-oxotetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-11-yl acetate
(1r,2s,3e,5s,7e,10r,13s)-2,10-bis(acetyloxy)-5-hydroxy-4-(hydroxymethyl)-8,12,15,15-tetramethyl-9-oxobicyclo[9.3.1]pentadeca-3,7,11-trien-13-yl acetate
(1'r,2s,2'r,3'r,5's,8'r,9'r,10'r)-9',10'-bis(acetyloxy)-5'-hydroxy-8',12',15',15'-tetramethyl-13'-oxospiro[oxirane-2,4'-tricyclo[9.3.1.0³,⁸]pentadecan]-11'-en-2'-yl acetate
(1r,2s,3r,4r,7s,9r,10r,11r,14s)-2,3-bis(acetyloxy)-7-hydroxy-4,14,16,16-tetramethyl-8-methylidene-13-oxo-15-oxatetracyclo[9.4.1.0¹,¹⁴.0⁴,⁹]hexadecan-10-yl acetate
2,8-bis(acetyloxy)-6,15-dihydroxy-5,5,9-trimethyl-14-methylidene-3-oxotetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-11-yl acetate
(1r,2s,3r,5s,7r,8s,9s,10s,11r,15s)-3,15-bis(acetyloxy)-9,10-dihydroxy-12,12-dimethyl-6-methylidene-17-oxapentacyclo[7.6.2.1⁵,⁸.0¹,¹¹.0²,⁸]octadecan-7-yl acetate
2,7-bis(acetyloxy)-6,11-dihydroxy-5,5,9-trimethyl-14-methylidene-15-oxotetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-3-yl acetate
(2r,4s,5s,7s,8e,10s,11r,13s)-2,10-bis(acetyloxy)-7,13-dihydroxy-4,14,15,15-tetramethyl-3-oxotricyclo[9.3.1.1⁴,⁸]hexadeca-1(14),8-dien-5-yl acetate
14-deoxo-14-O- acetylorthosiphol Y
{"Ingredient_id": "HBIN001404","Ingredient_name": "14-deoxo-14-O- acetylorthosiphol Y","Alias": "14-deoxo-14-o-acetylorthosiphol y","Ingredient_formula": "C26H36O9","Ingredient_Smile": "CC(=O)OC1CC2C(C(=O)C(=CC2(C3C1(C(C(CC3O)(C)C=C)OC(=O)C)O)C)OC(=O)C)(C)C","Ingredient_weight": "492.6 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "37493;5136","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "21578028","DrugBank_id": "NA"}
1-hydroxytaxinine a
{"Ingredient_id": "HBIN002663","Ingredient_name": "1-hydroxytaxinine a","Alias": "NA","Ingredient_formula": "C26H36O9","Ingredient_Smile": "CC1=C2C(C(C3(CCC(C(=C)C3C(C(C2(C)C)(CC1=O)O)OC(=O)C)O)C)OC(=O)C)OC(=O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT15918","TCMID_id": "10738","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
2α,7β,13α-triacetoxy-5α,9α-dihydroxy-2(3→20)abeotaxa-4(20),11-dien-10-one
{"Ingredient_id": "HBIN005252","Ingredient_name": "2\u03b1,7\u03b2,13\u03b1-triacetoxy-5\u03b1,9\u03b1-dihydroxy-2(3\u219220)abeotaxa-4(20),11-dien-10-one","Alias": "NA","Ingredient_formula": "C26H36O9","Ingredient_Smile": "CC(=O)OC1CC2CC3(C1C4(C(CC(C(C4C(=O)C3O)(C)C)O)OC(=O)C)C)C(C2=C)OC(=O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "21499","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
2-deacetyltaxine b
{"Ingredient_id": "HBIN005509","Ingredient_name": "2-deacetyltaxine b","Alias": "NA","Ingredient_formula": "C26H36O9","Ingredient_Smile": "CC1=C2C(C(=O)C3(CC(=CC(C(C2(C)C)CC1OC(=O)C)O)C(CC3OC(=O)C)O)C)OC(=O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "4780","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
2-deactyltaxine b
{"Ingredient_id": "HBIN005510","Ingredient_name": "2-deactyltaxine b","Alias": "NA","Ingredient_formula": "C26H36O9","Ingredient_Smile": "CC1=C2C(C(=O)C3(CC(=CC(C(C2(C)C)CC1OC(=O)C)O)C(CC3OC(=O)C)O)C)OC(=O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "30479","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
(3 e,7 e)-2α,10β,13α-triacetoxy-5α,20-dihydrox-y-3,8-seco-taxa-3,7,11-trien-9-one
{"Ingredient_id": "HBIN008454","Ingredient_name": "(3 e,7 e)-2\u03b1,10\u03b2,13\u03b1-triacetoxy-5\u03b1,20-dihydrox-y-3,8-seco-taxa-3,7,11-trien-9-one","Alias": "NA","Ingredient_formula": "C26H36O9","Ingredient_Smile": "CC(=O)OC1CC2CC3(C1C4(C(CC(C(C4C(=O)C3O)(C)C)O)OC(=O)C)C)C(C2=C)OC(=O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "21500","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
(3E,7E)-2alpha,10beta,13alpha-Triacetoxy-5alpha,20-dihydroxy-3,8-seco-taxa-3,7,11-trien-9-one
{"Ingredient_id": "HBIN008455","Ingredient_name": "(3E,7E)-2alpha,10beta,13alpha-Triacetoxy-5alpha,20-dihydroxy-3,8-seco-taxa-3,7,11-trien-9-one","Alias": "[(1R,2S,3E,5S,7E,10R,13S)-2,10-diacetyloxy-5-hydroxy-4-(hydroxymethyl)-8,12,15,15-tetramethyl-9-oxo-13-bicyclo[9.3.1]pentadeca-3,7,11-trienyl] acetate; acetic acid [(1R,2S,3E,5S,7E,10R,13S)-2,10-diacetoxy-5-hydroxy-9-keto-8,12,15,15-tetramethyl-4-methylol-13-bicyclo[9.3.1]pentadeca-3,7,11-trienyl] ester; (3e,7e)-2alpha,10beta,13alpha-triacetoxy-5alpha,20-dihydroxy-3,8-seco-taxa-3,7,11-trien-9-one; [(1R,2S,3E,5S,7E,10R,13S)-2,10-diacetoxy-5-hydroxy-4-(hydroxymethyl)-8,12,15,15-tetramethyl-9-oxo-13-bicyclo[9.3.1]pentadeca-3,7,11-trienyl] acetate; acetic acid [(1R,2S,3E,5S,7E,10R,13S)-2,10-diacetoxy-5-hydroxy-4-(hydroxymethyl)-8,12,15,15-tetramethyl-9-oxo-13-bicyclo[9.3.1]pentadeca-3,7,11-trienyl] ester; [(1R,2S,3E,5S,7E,10R,13S)-2,10-diacetyloxy-5-hydroxy-4-(hydroxymethyl)-8,12,15,15-tetramethyl-9-oxo-13-bicyclo[9.3.1]pentadeca-3,7,11-trienyl] ethanoate","Ingredient_formula": "C26H36O9","Ingredient_Smile": "CC1=CCC(C(=CC(C2CC(C(=C(C2(C)C)C(C1=O)OC(=O)C)C)OC(=O)C)OC(=O)C)CO)O","Ingredient_weight": "492.6 g/mol","OB_score": "7.933338771","CAS_id": "NA","SymMap_id": "SMIT01016","TCMID_id": "32087","TCMSP_id": "MOL003237","TCM_ID_id": "NA","PubChem_id": "6326196","DrugBank_id": "NA"}
adenanthin j
{"Ingredient_id": "HBIN014681","Ingredient_name": "adenanthin j","Alias": "NA","Ingredient_formula": "C26H36O9","Ingredient_Smile": "CC(=O)OC1CC2CC3(C1C4(C(CC(C(C4C(=O)C3OC(=O)C)(C)C)O)OC(=O)C)C)C(C2=C)O","Ingredient_weight": "492.6 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "614","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "11081505","DrugBank_id": "NA"}
adenanthin k
{"Ingredient_id": "HBIN014682","Ingredient_name": "adenanthin k","Alias": "NA","Ingredient_formula": "C26H36O9","Ingredient_Smile": "CC(=O)OC1CC2CC3(C1C4(C(CC(C(C4C(=O)C3O)(C)C)O)OC(=O)C)C)C(C2=C)OC(=O)C","Ingredient_weight": "492.6 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "615","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "11081506","DrugBank_id": "NA"}